| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |